• 1
    Lue TF Physiology of erection and pathophysiology of impotence. In Walsh PC, Retik AB, Stamey TA, Vaughan Jr ED, eds, Campbell’s Urology 6th edn, Saunders,1992; 709 28
  • 2
    Andersson KE & Wagner G Physiology of penile erection. Physiol Rev1995; 75: 191 236
  • 3
    Argiolas A & Melis MR Neuromodulation of penile erection. Prog Neurobiol1995; 47: 235 55
  • 4
    De Groat WC & Steers WD Neuroanatomy and neurophysiology of penile erection. In Tanagho EA, Lue, TF, McClure RD, eds, Contemporary Management of Impotence and Infertility, Chapt 1 Baltimore MD: Williams Wilkins,1988; 3 27
  • 5
    Hedlund H & Andersson KE Comparison of the responses to drugs acting on adrenoceptors and muscarinic receptors in isolated corpus cavernosum and cavernous artery. J Aut Pharmacol1985; 5: 81 8
  • 6
    Azadzoi KM, Kim N, Brown ML et al . Endothelium derived nitric oxide and cycloxygenase products modulate corpus cavernosum smooth muscle tone. J Urol1992; 147: 220 5
  • 7
    Palmer RMJ, Ferrige AG, Moncada S Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor. Nature1987; 327: 524 6
  • 8
    Ignarro LJ Biosynthesis and metabolism of endothelium derived nitric oxide. Ann Rev Toxicol Pharmacol1990; 30: 535 60
  • 9
    Moncada S, Palmer RMJ, Higgs EA Nitric oxide: physiology, pathophysiology and pharmacology. Pharm Rev1991; 43: 109 42
  • 10
    Rees DD, Palmer RM, Schulz R, Hodson HF, Moncada S Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol1990; 101: 746 52
  • 11
    Bredt DS & Snyder SH Nitric oxide: A physiological messenger molecule. Ann Rev Biochem1994; 57: 683 706
  • 12
    Burnett AL, Tillman SL, Chang TSK et al . Immunohistochemical localisation of nitric oxide synthase in the autonomic innervation of the human penis. J Urol1993; 150: 73 6
  • 13
    Trigo-Rocha F, Hsu GL, Donatucci CF, Lue TF The role of cyclic adenosine monophosphate, cyclic guanosine monophosphate, endothelium and nonadrenergic noncholinergic neurotransmission in canine penile erection. J Urol1993; 149: 872 7
  • 14
    Ignarro LJ, Bush PA, Buga GM, Wood KS, Fukoto JM, Rajfer J Nitric oxide and cyclic GMP formation upon electrical field stimulation causes relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Comm1990; 170: 843 50
  • 15
    Holmquist F, Hedlund H, Andersson KE L-NG-nitro arginine inhibits non-adrenergic, non-cholinergic relaxation of human isolated corpus cavernosum. Acta Physiol Scand1991; 141: 441 2
  • 16
    Pickard RS, Powell PH, Zar MA The effect of inhibitors of nitric oxide biosynthesis and cyclic GMP formation on nerve evoked relaxation of human cavernosal smooth muscle. Br J Pharmacol1991; 104: 755 9
  • 17
    Holmquist F, Andersson KE, Hedlund H Characterisation of inhibitory neurotransmission in the isolated corpus cavernosum from rabbit and man. J Physiol1992; 449: 295 311
  • 18
    Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ Nitric oxide as a mediator of the corpus cavernosum in response to non cholinergic, non adrenergic neurotransmission. New Engl J Med1992; 326: 90 4
  • 19
    Burnett AL, Lowenstein CJ, Bredt DS, Chang TSK, Snyder SH Nitric oxide: A physiological mediator of penile erection. Science1992; 257: 401 3
  • 20
    Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC Targeted disruption of the neuronal nitric oxide synthase gene. Cell1993; 75: 117 29
  • 21
    Burnett AL, Nelson RJ, Calvin DC et al . Nitric oxide dependent penile erection in mice lacking neuronal nitric oxide synthase. Mol Med1996; 2: 288 96
  • 22
    Boolell M, Allen MJ, Ballard SA et al . Sildenafil: an orally active type 5 cyclic GMP specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res1996; 8: 47 52
  • 23
    Ballard SA, Burslem MF, Gingell JC et al In vitro profile of UK-92, 480 for the treatment of male erectile dysfunction. J Urol1996; 155: 676A
  • 24
    Carter AJ, Ballard SA, Naylor AM Effect of sildenafil (VIAGRA ) on erectile function in the anaesthetised dog. J Urol1997; 157: 1398
  • 25
    Lue TF A study of sildenafil (VIAGRA™ ), a new oral agent for the treatment of male erectile dysfunction. J Urol1997; 157: 701
  • 26
    Brindley GS Pilot experiments on the actions of drugs injected into the human corpus cavernosum penis. Br J Pharmacol1986; 87: 495 500
  • 27
    Saenz de Tejada I, Blanco R, Goldstein I et al . Cholinergic neurotransmission in human corpus cavernosum. I. Response of isolated tissue. Am J Physiol1988; 254: H459–H467
  • 28
    Knispel H, Goessl C, Beckmann R Basal and acetylcholine stimulated nitric oxide formation mediates relaxation of rabbit cavernous smooth muscle. J Urol1991; 146: 1429 33
  • 29
    Wagner G & Brindley GS The effect of atropine and a and b blockers on human penile erection: a controlled pilot study. In Zorgniotti AW, Rossi G, eds, Vasculogenic Impotence, Chapt 10. Springfield IL: Thomas,1980; 77 81
  • 30
    Willis EA, Ottesen B, Wagner G, Sundler F, Fahrenkrug J Vasoactive intestinal polypeptide (VIP) as a putative neurotransmitter in penile erection. Life Sci1983; 33: 383 91
  • 31
    Steers WD, McConnell J, Benson GS Anatomical localisation and some pharmacological effects of vasoactive intestinal polypeptide in human and monkey corpus cavernosum. J Urol1984; 132: 1048 53
  • 32
    Hedlund H & Andersson KE Effects of some peptides on isolated human penile erectile tissue and cavernous artery. Acta Physiol Scand1985; 124: 413 9
  • 33
    Adaikan PG, Kottegoda SR, Ratnam SS Is vasoactive intestinal polypeptide the principal transmitter involved in human penile erection. J Auton Pharmacol1986; 135: 638 40
  • 34
    Kim YC, Kim JH, Davies MG, Hagen PO, Carson CC, 3rd 3rd Modulation of vasoactive intestinal polypeptide (VIP)-mediated relaxation by nitric oxide and prostanoids in the rabbit corpus cavernosum . J Urol 1995;153: 807 10
  • 35
    Pickard RS, Powell PH, Zar MA Evidence against vasoactive intestinal polypeptide as the relaxant neurotransmitter in human cavernosal smooth muscle . Br J Pharmacol 1993;108: 497 500
  • 36
    Wagner G & Gerstenberg T Intracavernous injection of vasoactive intestinal polypeptide (VIP does not produce erection in man per se). World J Urol1987; 5: 171 7
  • 37
    Kiely EA, Bloom SR, Williams G Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents. Br J Urol1989; 64: 191 4
  • 38
    Roy JB, Petrone RL, Said SI A clinical trial of intracavernous vasoactive intestinal peptide to induce penile erection. J Urol1990; 143: 302 4
  • 39
    Gerstenberg TC, Metz P, Ottesen B, Fahrenkrug J Intracavernous self-injection with vasoactive intestinal polypeptide and phentolamine in the management of erectile failure. J Urol1992; 147: 1277 9
  • 40
    Wahlestedt C & Reis DJ Neuropeptide Y related peptides and their receptors — are the receptors potential therapeutic drug targets? Ann Rev1993; 32: 309 52
  • 41
    Adrian TE, Gu J, Allen JM, Tatemoto K, Polak JM, Bloom SR Neuropeptide Y in the human male genital tract. Life Sci1984; 35: 2643 8
  • 42
    Kirkeby HJ, Jorgensen JC, Ottesen B Neuropeptide Y (NPY) in human penile corpus cavernosum tissue and circumflex veins— occurrence and in vitro1991; 145: 605 9
  • 43
    Holmquist F, Andersson KE, Hedlund H Actions of endothelin on isolated corpus cavernosum from rabbit and man. Acta Physiol Scand1990; 139: 113 22
  • 44
    Saenz de Tejada I, Carson MP, De Las Morenas A, Goldstein I, Traish AM Endothelin: localization, synthesis, activity, and receptor types in human penile corpus cavernosum. Am J Physiol1991; 261: H1078–H1085
  • 45
    Baraldi M, Benassi-Benelli A, Lolli M Penile erections in rats after fenfluramine administration. Riv Farmacol Ter1977; 8: 375 9
  • 46
    Szele FG, Murphy DL, Garrick NA Effects of fenfluramine, m-chlorophenylpiperazine, and other serotonin-related agonists and antagonists on penile erections in nonhuman primates. Life Sci1988; 43: 1297 303
  • 47
    Azadzoi KM, Payton T, Krane RJ, Goldstein I Effects of intracavernosal trazodone hydrochloride: animal and human studies. J Urol1990; 144: 1277 82
  • 48
    Scher M, Krieger JN, Juergens S Trazodone and priapism. Am J Psychiatry1983; 140: 1362 3
  • 49
    Berendsen HH, Jenck F, Broekkamp CL Involvement of 5-HT1C-receptors in drug-induced penile erections in rats. Psychopharmacol1990; 101: 57 61
  • 50
    Pomerantz SM, Hepner BC, Wertz JM Serotonergic influences on male sexual behavior of rhesus monkeys: effects of serotonin agonists. Psychopharmacol1993; 111: 47 54
  • 51
    Alexander SPH & Peters JA Receptor and ion channel nomenclature supplement. Trends Pharmacol Sci, 8th edn1997; 47
  • 52
    Millan MJ, Peglion J-L, Lavielle G, Perrin-Monneyron S 5-HT2C-receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists. Eur J Pharmacol1997; 325: 9 12
  • 53
    Benassi-Benelli A, Ferrari F, Quarontotti BP Penile erection induced by apomorphine and N-n-propyl-norapomorphine in rats. Arch Int Pharmacodyn Ther1979; 242: 241 7
  • 54
    Lal S, Ackman D, Thavundayil JX, Kiely ME, Etienne P Effect of apomorphine, a dopamine receptor agonist, on penile tumescence in normal subjects. Prog Neuropsychopharmacol Biol Psychiat1984; 8: 695 9
  • 55
    Lal S, Tesfaye Y, Thavundayil JX et al . Apomorphine: clinical studies on erectile impotence and yawning. Prog Neuropsychopharmacol Biol Psychiat1989; 13: 329 39
  • 56
    Melis MR & Argiolas A Dopamine and sexual behavior. Neurosci Biobehav Rev1995; 19: 19 38
  • 57
    Melis MR, Succu S, Argiolas A Dopamine agonists increase nitric oxide production in the paraventricular nucleus of the hypothalamus: correlation with penile erection and yawning. Eur J Neurosci1996; 8: 2056 63
  • 58
    Melis MR & Argiolas A Nitric oxide synthase inhibitors prevent apomorphine- and oxytocin-induced penile erection and yawning in male rats. Brain Res Bull1993; 32: 71 4
  • 59
    Heaton JP, Morales A, Adams MA, Johnston B, El-Rashidy R Recovery of erectile function by the oral administration of apomorphine. Urology1995; 45: 200 6
  • 60
    Melis MR, Stancampiano R, Argiolas A The role of nitric oxide in penile erection and yawning induced by 5HT1C agonists in male rats. Naunyn Schmiedeberg’s Arch Pharmacol1995; 351: 439 46
  • 61
    Argiolas A Nitric oxide is a central mediator of penile erection. Neuropharmacology1994; 33: 1339 44
  • 62
    Melis MR, Stancampiano R, Lai C, Argiolas A Nitroglycerin-induced penile erection and yawning in male rats: mechanism of action in the brain. Brain Res Bull1995; 36: 527 31
  • 63
    Melis MR & Argiolas A Nitric oxide donors induce penile erection and yawning when injected in the central nervous system of male rats. Eur J Pharmacol1995; 294: 1 9
  • 64
    Clark JT, Smith ER, Davidson JM Testosterone is not required for the enhancement of sexual motivation by yohimbine. Physiol Behav1985; 35: 517 21
  • 65
    Morales A, Condra M, Owen JA, Surridge DH, Fenemore J, Harris C Is yohimbine effective in the treatment of organic impotence? Results of a controlled trial. J Urol1987; 137: 1168 72
  • 66
    Susset JG, Tessier CD, Wincze J, Bansal S, Malhotra C, Schwacha MG Effect of yohimbine hydrochloride on erectile impotence: a double-blind study. J Urol1989; 141: 1360 3
  • 67
    Munoz M, Bancroft J, Beard M Evaluating the effects of an alpha-2 adrenoceptor antagonist on erectile function in the human male. 2. The erectile response to erotic stimuli in men with erectile dysfunction, in relation to age and in comparison with normal volunteers. Psychopharmacology1994; 115: 471 7
  • 68
    Bancroft J, Munoz M, Beard M, Shapiro C The effects of a new alpha-2 adrenoceptor antagonist on sleep and nocturnal penile tumescence in normal male volunteers and men with erectile dysfunction. Psychosom Med1995; 57: 345 56
  • 69
    Robinson ICAF The magnocellular and parvocellular OT and AVP systems. In Lightman SL, Everitt BJ, eds, Neuroendocrinology. Oxford: Blackwells,1986; 154 68
  • 70
    Sofroniew MV Morphology of vasopressin and oxytocin neurones and their central and vascular projections. In Cross BA, Leng G, eds, The Neurohypophysis: Structure, Function and Control. Progress in Brain Research, 60. Amsterdam: Elsevier,1983; 101 14
  • 71
    Richard P, Moos F, Freund-Mercier MJ Central effects of oxytocin. Physiol Rev1991; 71: 331 70
  • 72
    Carter CS Oxytocin and sexual behavior. Neurosci Biobehav Rev1992; 16: 1310144
  • 73
    Argiolas A Oxytocin stimulation of penile erection. Pharmacology, site, and mechanism of action. Ann NY Acad Sci1992; 652: 194 203
  • 74
    Argiolas A, Melis MR, Vargiu L, Gessa GL d (CH2) 5Tyr (Me)-[Orn8]vasotocin, a potent oxytocin antagonist, antagonizes penile erection and yawning induced by oxytocin and apomorphine, but not by ACTH-(1–24). Eur J Pharmacol1987; 134: 221 4
  • 75
    Bertolini A, Gessa GL, Ferrari W Penile erection and ejaculation: A central effect of ACTH-like peptides in mammals. In Sandler M, Gessa GL, eds, Sexual behavior New York: Raven Press1975; 247 57
  • 76
    Domer FR, Wessler G, Brown RL, Matthews A Effects of naloxone on penile erection in cats. Pharmacol Biochem Behav1988; 30: 543 5
  • 77
    Cushman P Sexual behavior in heroine addiction and methadome maintenance. NY State J Med1972; 72: 1261 6